SCHEMBL10073040

SCHEMBL10073040

CCCCOc1ccc(C2(CNC(=O)C(c3ccccc3)c3ccccc3)CCCC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
LMNA P02545 4/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
NPSR1 Q6W5P4 3/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
MAPT P10636 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
HTT P42858 1/20 0.54
RAB9A P51151 1/20 0.54
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
P2RX7 Q99572 1/20 0.47
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
SLC6A5 Q9Y345 1/20 0.45
GPR88 Q9GZN0 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073045 0.83 LMNA (0.62) ALDH1A1LMNASMN1; SMN2NPSR1CYP3A4
SCHEMBL9818699 0.79 ALDH1A1 (0.60) ALDH1A1LMNASMN1; SMN2NPSR1CYP1A2
SCHEMBL558753 0.77 ALDH1A1 (0.68) ALDH1A1LMNACYP1A2CYP3A4MAPT
SCHEMBL8120294 0.75 HDAC10 (0.60) ALDH1A1SMN1; SMN2NPSR1CYP1A2CYP2D6
SCHEMBL19242659 0.74 ALDH1A1 (0.50) ALDH1A1LMNASMN1; SMN2NPSR1CYP1A2
SCHEMBL19242763 0.73 ALDH1A1 (0.49) ALDH1A1LMNASMN1; SMN2NPSR1CYP1A2
SCHEMBL19242668 0.72 ALDH1A1 (0.48) ALDH1A1LMNASMN1; SMN2NPSR1CYP1A2
SCHEMBL27798300 0.72 GPR88 (0.59) ALDH1A1LMNANPSR1TSHRGPR88
SCHEMBL20490447 0.70 GPR88 (0.53) ALDH1A1NPSR1KMT2AGPR88
SCHEMBL9818716 0.70 NPC1 (0.59) LMNAMAPTRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-10 US disclosed
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2012-02-09 US disclosed
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-20 US disclosed
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-20 US disclosed
US-7598412-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-10-06 US disclosed
US-7598412-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 ALDH1A1 895/4885LMNA 1873/4885SMN1; SMN2 3617/4885
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters ABCB11, ABCB1, ABCC5 ALDH1A1 895/4885LMNA 1873/4885SMN1; SMN2 3617/4885
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 ALDH1A1 895/4885LMNA 1873/4885SMN1; SMN2 3617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.